Trinity Biotech (TRIB)

0.57

0.00 (0.00%)

At close: Apr 01, 2025, 3:58 PM

0.60

4.62%

After-hours: Apr 01, 2025, 07:21 PM EDT

Trinity Biotech Cash Flow Statement

Chart Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-24.02M	-41.01M	875K	-6.39M	12.2M
Depreciation & Amortization	1.78M	2.33M	2.74M	3.08M	4.89M
Stock-Based Compensation	2.07M	1.75M	1.1M	792K	758K
Other Working Capital	1.00	7.39M	5.59M	5.06M	1.57M
Other Non-Cash Items	11.37M	37.85M	8.86M	22.31M	-10.57M
Deferred Income Tax	-59K	-192K	-167K	-182K	-1.01M
Change in Working Capital	-2.69M	-1.66M	-172K	4.14M	-796K
Operating Cash Flow	-11.56M	-921K	13.24M	23.75M	5.47M
Capital Expenditures	-803K	-5.98M	-8.69M	-10.2M	-15.36M
Acquisitions	28.16M	n/a	n/a	n/a	n/a
Purchase of Investments	-700K	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-1.9M	-4.88M	-6.88M	-6.99M	-3.06M
Investing Cash Flow	24.76M	-5.98M	-8.69M	-10.2M	-15.36M
Debt Repayment	-7.37M	-27.04M	-2.94M	-3.24M	-3.53M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-8.67M	14.72M	-3.08M	524K	-4M
Financial Cash Flow	-16.04M	-12.32M	-6.02M	-2.72M	-4M
Net Cash Flow	-2.89M	-19.33M	-1.42M	10.93M	-13.88M
Free Cash Flow	-14.26M	-6.9M	4.55M	13.56M	-9.88M